Helicobacter pylori infection and gastric outlet obstruction — prevalence of the infection and role of antimicrobial treatment
Intestinal metaplasia and gastric carcinogenesis
The burden of illness of non-cardiac chest pain
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
Induction and maintenance of clinical remission by interferon-β in patients with steroid-refractory active ulcerative colitis—an open long-term pilot trial
The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading
One-week triple vs. quadruple therapy for Helicobacter pylori infection — a randomized trial
Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy
Furazolidone-based triple ‘rescue therapy’ vs. quadruple ‘rescue therapy’ for the eradication of Helicobacter pylori resistant to metronidazole
Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis
Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects
An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy
Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity
Low-salt bowel cleansing preparation (LoSo Prep) as preparation for colonoscopy: a pilot study
Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years
Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control
Prucalopride, a systemic enterokinetic, for the treatment of constipation
The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas